13D/13G Filings - Aardvark Therapeutics Inc. (AARD)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-02-24
5:55 pm
Purchase
2025-02-1413GAardvark Therapeutics, Inc. Common Stock
AARD
CITADEL ADVISORS LLC1,192,971
5.600%
1,192,971increase
(New Position)
Filing
History
2025-02-24
4:16 pm
Purchase
2025-02-1413GAardvark Therapeutics, Inc. Common Stock
AARD
Decheng Capital Global Life Sciences Fund IV, L.P.3,917,299
18.300%
3,917,299increase
(New Position)
Filing
History
2025-02-24
07:00 am
Purchase
2025-02-1213GAardvark Therapeutics, Inc. Common Stock
AARD
Dr. Finian Tan2,050,902
9.580%
2,050,902increase
(New Position)
Filing
History